SPC 100270

Known as: SPC-100270 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2017
0119842017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
OBJECTIVE To compare duration of surgery, recurrence rate, and survival time between cats with idiopathic chylothorax treated… (More)
Is this relevant?
2017
2017
OBJECTIVE The aim of this study was to examine the impact of deliberate employment of postoperative hypotension on delayed… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 2
Is this relevant?
Review
1996
Review
1996
Since protein kinase C (PKC) has been proven to be a mediator of neutrophil activation and of intracellular calcium homeostasis… (More)
Is this relevant?
1995
1995
SPC-100270 drug substance ((2S,3S)-2-aminooctadecane-1,3-diol) is a synthetic sphingosine analogue possessing limited ultraviolet… (More)
Is this relevant?
1994
1994
Recently, we reported that SPC-100270, a sphingosine derivative and inhibitor of protein kinase C (50-90 microM) in mixed micelle… (More)
Is this relevant?
1984
1984
Normal rat tracheal epithelial cells require exogenous pyruvate to survive in culture while carcinogen-altered cells do not. The… (More)
Is this relevant?